{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03183661",
      "OrgStudyIdInfo": {
        "OrgStudyId": "ALLO-ASC-CD-102"
      },
      "Organization": {
        "OrgFullName": "Anterogen Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial",
      "OfficialTitle": "Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in the Subjects With CrohnÂ´s Disease(ALLO-ASC-CD-101)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2017",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Enrolling by invitation",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 16, 2016",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 31, 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 30, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "June 8, 2017",
      "StudyFirstSubmitQCDate": "June 8, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 12, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "June 8, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 12, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Anterogen Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-CD injection in phase 1 clinical trial (ALLO-ASC-CD-101) for 36 months.",
      "DetailedDescription": "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-CD injection in phase 1 clinical trial (ALLO-ASC-CD-101) for 36 months.\n\nALLO-ASC-CD is intravenous infusion containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells are directed to injured tissue, and reduce inflammation. Furthermore their immunomodulatory effects are significant for treating immune-related disease, such as crohn's disease. Finally, ALLO-ASC-CD may provide a new option in treating a crohn's disease."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Crohn Disease"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "No",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Case-Only"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "9",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "ALLO-ASC-CD injection",
            "ArmGroupDescription": "Subjects with ALLO-ASC-CD injection in phase 1 clinical trial of ALLOASC-CD-101",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: ALLO-ASC-CD"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "ALLO-ASC-CD",
            "InterventionDescription": "ALLO-ASC-CD is intravenous infusion containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells are directed to injured tissue, and reduce inflammation. Furthermore their immunomodulatory effects are significant for treating immune-related disease. Finally, ALLO-ASC-CD may provide a new option in treating a crohn's disease. This study is a follow-up study without intervention.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "ALLO-ASC-CD injection"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Allogenic adipose-derived mesenchymal stem cell"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number of Participants with Adverse Events as a Measure of Safety and Tolerability",
            "PrimaryOutcomeDescription": "Evaluation of AE",
            "PrimaryOutcomeTimeFrame": "up to 36 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSubjects who are injected with ALLO-ASC-CD in phase 1 clinical trial of ALLO-ASC-CD-101.\nSubjects who are able to give written informed consent prior to study start and to comply with the study requirements.\n\nExclusion Criteria:\n\n1. Subjects who are considered not suitable for the study by the principal investigator.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "Subject is enrolled who are injected ALLO-ASC-CD intravenous infusion in phase 1 clinical trial of ALLO-ASC-CD-101.",
      "SamplingMethod": "Probability Sample"
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Won Ho Kim, Ph D",
            "OverallOfficialAffiliation": "Yonsei University",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Joo Sung Kim, Ph D",
            "OverallOfficialAffiliation": "Seoul National University Hospital",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Young Ho Kim, Ph D",
            "OverallOfficialAffiliation": "Samsung Medical Center",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003424",
            "ConditionMeshTerm": "Crohn Disease"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000015212",
            "ConditionAncestorTerm": "Inflammatory Bowel Diseases"
          },
          {
            "ConditionAncestorId": "D000005759",
            "ConditionAncestorTerm": "Gastroenteritis"
          },
          {
            "ConditionAncestorId": "D000005767",
            "ConditionAncestorTerm": "Gastrointestinal Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          },
          {
            "ConditionAncestorId": "D000007410",
            "ConditionAncestorTerm": "Intestinal Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M5790",
            "ConditionBrowseLeafName": "Crohn Disease",
            "ConditionBrowseLeafAsFound": "Crohn's Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9596",
            "ConditionBrowseLeafName": "Intestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M17069",
            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8027",
            "ConditionBrowseLeafName": "Gastroenteritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}